Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 111

1.

Impact of Pulmonary Hypertension Hemodynamic Status on Long-Term Outcome After Transcatheter Aortic Valve Replacement.

Schewel J, Schmidt T, Kuck KH, Frerker C, Schewel D.

JACC Cardiovasc Interv. 2019 Nov 11;12(21):2155-2168. doi: 10.1016/j.jcin.2019.08.031.

PMID:
31699377
2.

Systematic Review and Meta-Analysis of Interventional Emergency Treatment of Decompensated Severe Aortic Stenosis.

Wernly B, Jirak P, Lichtenauer M, Veulemans V, Zeus T, Piayda K, Hoppe UC, Lauten A, Frerker C, Jung C.

J Invasive Cardiol. 2019 Oct 15. pii: JIC20191015-3. [Epub ahead of print]

3.

Transcatheter versus medical treatment of symptomatic severe tricuspid regurgitation.

Taramasso M, Benfari G, van der Bijl P, Alessandrini H, Attinger-Toller A, Biasco L, Lurz P, Braun D, Brochet E, Connelly KA, de Bruijn S, Denti P, Deuschl F, Estevez-Loureiro R, Fam N, Frerker C, Gavazzoni M, Hausleiter JR, Ho E, Juliard JM, Kaple R, Besler C, Kodali S, Kreidel F, Kuck KH, Latib A, Lauten A, Monivas V, Mehr M, Muntané-Carol G, Nazif T, Nickening G, Pedrazzini G, Philippon F, Pozzoli A, Praz F, Puri R, Rodés-Cabau J, Scha Fer U, Schofer J, Sievert H, Tang GHL, Thiele H, Topilsky Y, Rommel KP, Delgado V, Vahanian A, Von Bardeleben RS, Webb JG, Weber M, Windecker S, Winkel M, Zuber M, Leon MB, Hahn RT, Bax JJ, Enriquez-Sarano M, Maisano F.

J Am Coll Cardiol. 2019 Sep 24. pii: S0735-1097(19)37739-3. doi: 10.1016/j.jacc.2019.09.028. [Epub ahead of print]

PMID:
31568868
4.

Early Hemodynamic Changes and Long-Term Outcome Of Patients With Severe Low Gradient Aortic Stenosis After Transcatheter Aortic Valve Replacement.

Schewel J, Schlüter M, Schmidt T, Kuck KH, Frerker C, Schewel D.

EuroIntervention. 2019 Oct 1. pii: EIJ-D-19-00399. doi: 10.4244/EIJ-D-19-00399. [Epub ahead of print]

5.

[Transcatheter aortic valve replacement : PARTNER 3 trial and Evolut Low Risk Trial].

Frerker C, Baldus S, Nitschmann S.

Internist (Berl). 2019 Nov;60(11):1221-1224. doi: 10.1007/s00108-019-00663-5. German. No abstract available.

PMID:
31486860
6.

1-Year Outcomes After Edge-to-Edge Valve Repair for Symptomatic Tricuspid Regurgitation: Results From the TriValve Registry.

Mehr M, Taramasso M, Besler C, Ruf T, Connelly KA, Weber M, Yzeiraj E, Schiavi D, Mangieri A, Vaskelyte L, Alessandrini H, Deuschl F, Brugger N, Ahmad H, Biasco L, Orban M, Deseive S, Braun D, Rommel KP, Pozzoli A, Frerker C, Näbauer M, Massberg S, Pedrazzini G, Tang GHL, Windecker S, Schäfer U, Kuck KH, Sievert H, Denti P, Latib A, Schofer J, Nickenig G, Fam N, von Bardeleben S, Lurz P, Maisano F, Hausleiter J.

JACC Cardiovasc Interv. 2019 Aug 12;12(15):1451-1461. doi: 10.1016/j.jcin.2019.04.019.

PMID:
31395215
7.

[Cardioband®: Where do we stand, who are suitable patients?]

Frerker C, Schmidt T, Pfister R, Körber MI, Mauri V, Wösten M, Baldus S.

Herz. 2019 Nov;44(7):596-601. doi: 10.1007/s00059-019-4839-y. German.

PMID:
31372675
8.

Thirty-day outcomes of a novel transcatheter heart valve to treat degenerated surgical valves: the VIVALL multicentre, single-arm, pilot study.

Schäfer U, Butter C, Landt M, Frerker C, Treede H, Schirmer J, Koban C, Allali A, Schmidt T, Charitos E, Conradi L.

EuroIntervention. 2019 Oct 4;15(9):e757-e763. doi: 10.4244/EIJ-D-19-00331.

9.

Pulmonary hypertension and valvular heart disease.

Tichelbäcker T, Dumitrescu D, Gerhardt F, Stern D, Wissmüller M, Adam M, Schmidt T, Frerker C, Pfister R, Halbach M, Baldus S, Rosenkranz S.

Herz. 2019 Sep;44(6):491-501. doi: 10.1007/s00059-019-4823-6. Review.

PMID:
31312873
10.

Outcomes of transcatheter aortic valve replacement without predilation of the aortic valve: Insights from 1544 patients included in the SOURCE 3 registry.

Dumonteil N, Terkelsen C, Frerker C, Collart F, Wöhrle J, Butter C, Hovorka T, Pinaud F, Baumgartner H, Tarantini G, Wendler O, Lefèvre T; SOURCE 3 Investigators.

Int J Cardiol. 2019 Dec 1;296:32-37. doi: 10.1016/j.ijcard.2019.06.013. Epub 2019 Jun 12.

11.

Incidence and outcome of peri-procedural transcatheter heart valve embolization and migration: the TRAVEL registry (TranscatheteR HeArt Valve EmboLization and Migration).

Kim WK, Schäfer U, Tchetche D, Nef H, Arnold M, Avanzas P, Rudolph T, Scholtz S, Barbanti M, Kempfert J, Mangieri A, Lauten A, Frerker C, Yoon SH, Holzamer A, Praz F, De Backer O, Toggweiler S, Blumenstein J, Purita P, Tarantini G, Thilo C, Wolf A, Husser O, Pellegrini C, Burgdorf C, Antolin RAH, Díaz VAJ, Liebetrau C, Schofer N, Möllmann H, Eggebrecht H, Sondergaard L, Walther T, Pilgrim T, Hilker M, Makkar R, Unbehaun A, Börgermann J, Moris C, Achenbach S, Dörr O, Brochado B, Conradi L, Hamm CW.

Eur Heart J. 2019 Oct 7;40(38):3156-3165. doi: 10.1093/eurheartj/ehz429.

PMID:
31230081
12.

Impact of new pacemaker implantation following surgical and transcatheter aortic valve replacement on 1-year outcome.

Fujita B, Schmidt T, Bleiziffer S, Bauer T, Beckmann A, Bekeredjian R, Möllmann H, Walther T, Landwehr S, Hamm C, Beyersdorf F, Katus HA, Harringer W, Ensminger S, Frerker C.

Eur J Cardiothorac Surg. 2019 Jun 14. pii: ezz168. doi: 10.1093/ejcts/ezz168. [Epub ahead of print]

PMID:
31199470
13.

The clip and the tip: Lessons learned from ablation of atrial fibrillation in patients postpercutaneous mitral valve repair.

Rottner L, Lemes C, Dotz I, Wohlmuth P, Schmidt T, Mathew S, Heeger CH, Reissmann B, Fink T, Rillig A, Frerker C, Ouyang F, Kuck KH, Metzner A, Maurer T.

J Cardiovasc Electrophysiol. 2019 Aug;30(8):1207-1214. doi: 10.1111/jce.13964. Epub 2019 May 21.

PMID:
31045293
14.

Successful balloon valvuloplasty of rheumatic mitral valve stenosis in a pregnant patient without fluoroscopy: a case report.

Ubben T, Frerker C, Kuck KH, Schmidt T.

Eur Heart J Case Rep. 2018 May 16;2(2):yty058. doi: 10.1093/ehjcr/yty058. eCollection 2018 Jun.

15.

Treatment Challenges in Patients with Acute Heart Failure and Severe Aortic Valve Stenosis.

Schmidt T, Frerker C.

Curr Cardiol Rep. 2019 Apr 22;21(6):47. doi: 10.1007/s11886-019-1135-7. Review.

PMID:
31011842
16.

Predictive impact of previous coronary artery bypass grafting on mortality after MitraClip implantation for ischemic functional mitral regurgitation.

Kitamura M, Kaneko H, Schlüter M, Schewel D, Schmidt T, Alessandrini H, Kreidel F, Okamoto M, Neuss M, Butter C, Kuck KH, Frerker C.

Int J Cardiol. 2019 Jun 15;285:21-26. doi: 10.1016/j.ijcard.2019.02.045. Epub 2019 Mar 1.

PMID:
30871803
17.

One-Year Outcomes of a European Transcatheter Aortic Valve Implantation Cohort According to Surgical Risk.

Tarantini G, Lefèvre T, Terkelsen CJ, Frerker C, Ohlmann P, Mojoli M, Eltchaninoff H, Pinaud F, Redwood S, Windecker S.

Circ Cardiovasc Interv. 2019 Jan;12(1):e006724. doi: 10.1161/CIRCINTERVENTIONS.118.006724.

PMID:
30630356
18.

Outcomes After Current Transcatheter Tricuspid Valve Intervention: Mid-Term Results From the International TriValve Registry.

Taramasso M, Alessandrini H, Latib A, Asami M, Attinger-Toller A, Biasco L, Braun D, Brochet E, Connelly KA, Denti P, Deuschl F, Englmeier A, Fam N, Frerker C, Hausleiter J, Himbert D, Ho EC, Juliard JM, Kaple R, Kreidel F, Kuck KH, Ancona M, Lauten A, Lurz P, Mehr M, Nazif T, Nickening G, Pedrazzini G, Pozzoli A, Praz F, Puri R, Rodés-Cabau J, Schäfer U, Schofer J, Sievert H, Sievert K, Tang GHL, Tanner FC, Vahanian A, Webb JG, Windecker S, Yzeiray E, Zuber M, Maisano F, Leon MB, Hahn RT.

JACC Cardiovasc Interv. 2019 Jan 28;12(2):155-165. doi: 10.1016/j.jcin.2018.10.022. Epub 2018 Dec 26.

PMID:
30594510
19.

Patients at Intermediate Surgical Risk Undergoing Isolated Interventional or Surgical Aortic Valve Implantation for Severe Symptomatic Aortic Valve Stenosis.

Werner N, Zahn R, Beckmann A, Bauer T, Bleiziffer S, Hamm CW, Berkeredjian R, Berkowitsch A, Mohr FW, Landwehr S, Katus HA, Harringer W, Ensminger S, Frerker C, Möllmann H, Walther T, Schneider S, Lange R; GARY Executive Board.

Circulation. 2018 Dec 4;138(23):2611-2623. doi: 10.1161/CIRCULATIONAHA.117.033048.

PMID:
30571255
20.

The impact of biventricular heart failure on outcomes after transcatheter aortic valve implantation.

Schmidt T, Bohné M, Schlüter M, Kitamura M, Wohlmuth P, Schewel D, Schewel J, Schmoeckel M, Kuck KH, Frerker C.

Clin Res Cardiol. 2019 Jul;108(7):741-748. doi: 10.1007/s00392-018-1400-6. Epub 2018 Dec 3.

PMID:
30506481
21.

Bioprosthetic Valve Performance After Transcatheter Aortic Valve Replacement With Self-Expanding Versus Balloon-Expandable Valves in Large Versus Small Aortic Valve Annuli: Insights From the CHOICE Trial and the CHOICE-Extend Registry.

Abdelghani M, Mankerious N, Allali A, Landt M, Kaur J, Sulimov DS, Merten C, Sachse S, Mehilli J, Neumann FJ, Frerker C, Kurz T, El-Mawardy M, Richardt G, Abdel-Wahab M.

JACC Cardiovasc Interv. 2018 Dec 24;11(24):2507-2518. doi: 10.1016/j.jcin.2018.07.050. Epub 2018 Nov 28.

PMID:
30503595
22.

Impact of prosthesis-iteration evolution and sizing practice on the incidence of prosthesis-patient mismatch after transcatheter aortic valve replacement.

Abdelghani M, Allali A, Kaur J, Hemetsberger R, Mehilli J, Neumann FJ, Frerker C, Kurz T, El-Mawardy M, Richardt G, Abdel-Wahab M.

Catheter Cardiovasc Interv. 2019 Apr 1;93(5):971-979. doi: 10.1002/ccd.27977. Epub 2018 Nov 23.

PMID:
30467966
23.

Patients at low surgical risk as defined by the Society of Thoracic Surgeons Score undergoing isolated interventional or surgical aortic valve implantation: in-hospital data and 1-year results from the German Aortic Valve Registry (GARY).

Bekeredjian R, Szabo G, Balaban Ü, Bleiziffer S, Bauer T, Ensminger S, Frerker C, Herrmann E, Beyersdorf F, Hamm C, Beckmann A, Möllmann H, Karck M, Katus HA, Walther T.

Eur Heart J. 2019 May 1;40(17):1323-1330. doi: 10.1093/eurheartj/ehy699.

PMID:
30445543
24.

Outcomes of transcatheter mitral valve replacement for degenerated bioprostheses, failed annuloplasty rings, and mitral annular calcification.

Yoon SH, Whisenant BK, Bleiziffer S, Delgado V, Dhoble A, Schofer N, Eschenbach L, Bansal E, Murdoch DJ, Ancona M, Schmidt T, Yzeiraj E, Vincent F, Niikura H, Kim WK, Asami M, Unbehaun A, Hirji S, Fujita B, Silaschi M, Tang GHL, Kuwata S, Wong SC, Frangieh AH, Barker CM, Davies JE, Lauten A, Deuschl F, Nombela-Franco L, Rampat R, Nicz PFG, Masson JB, Wijeysundera HC, Sievert H, Blackman DJ, Gutierrez-Ibanes E, Sugiyama D, Chakravarty T, Hildick-Smith D, de Brito FS Jr, Jensen C, Jung C, Smalling RW, Arnold M, Redwood S, Kasel AM, Maisano F, Treede H, Ensminger SM, Kar S, Kaneko T, Pilgrim T, Sorajja P, Van Belle E, Prendergast BD, Bapat V, Modine T, Schofer J, Frerker C, Kempfert J, Attizzani GF, Latib A, Schaefer U, Webb JG, Bax JJ, Makkar RR.

Eur Heart J. 2019 Feb 1;40(5):441-451. doi: 10.1093/eurheartj/ehy590.

PMID:
30357365
25.

Predictors of mortality in ischaemic versus non-ischaemic functional mitral regurgitation after successful transcatheter mitral valve repair using MitraClip: results from two high-volume centres.

Kitamura M, Kaneko H, Schlüter M, Schewel D, Schmidt T, Alessandrini H, Kreidel F, Neuss M, Butter C, Kuck KH, Frerker C.

Clin Res Cardiol. 2019 Mar;108(3):264-272. doi: 10.1007/s00392-018-1352-x. Epub 2018 Aug 10.

PMID:
30097683
26.

Urgent balloon aortic valvuloplasty in cardiogenic shock patients: still state of the art in the TAVI era?

Frerker C.

EuroIntervention. 2018 Aug 3;14(5):e494-e495. doi: 10.4244/EIJV14I5A87. No abstract available.

27.

Reply: Rapid Deployment But Not Hasty Conclusions.

Ensminger S, Fujita B, Frerker C; GARY Executive Board.

J Am Coll Cardiol. 2018 Jul 31;72(5):589-590. doi: 10.1016/j.jacc.2018.05.032. No abstract available.

28.

MitraClip in Patients With Mitral Regurgitation and Left Ventricular Ejection Fraction <30% - Potential Implications for the Treatment of Patients in Japan.

Kaneko H, Kitamura M, Neuss M, Okamoto M, Schmidt T, Alessandrini H, Kuck KH, Komuro I, Frerker C, Butter C.

Circ J. 2018 Sep 25;82(10):2672-2675. doi: 10.1253/circj.CJ-18-0536. Epub 2018 Jul 25.

29.

Debris Heterogeneity Across Different Valve Types Captured by a Cerebral Protection System During Transcatheter Aortic Valve Replacement.

Schmidt T, Leon MB, Mehran R, Kuck KH, Alu MC, Braumann RE, Kodali S, Kapadia SR, Linke A, Makkar R, Naber C, Romero ME, Virmani R, Frerker C.

JACC Cardiovasc Interv. 2018 Jul 9;11(13):1262-1273. doi: 10.1016/j.jcin.2018.03.001.

30.

Cerebral Protection During Catheter Ablation of Ventricular Tachycardia in Patients With Ischemic Heart Disease.

Heeger CH, Metzner A, Schlüter M, Rillig A, Mathew S, Tilz RR, Wohlmuth P, Romero ME, Virmani R, Fink T, Reissmann B, Lemes C, Maurer T, Santoro F, Schmidt T, Ghanem A, Frerker C, Kuck KH, Ouyang F.

J Am Heart Assoc. 2018 Jun 30;7(13). pii: e009005. doi: 10.1161/JAHA.118.009005.

31.

Transcatheter aortic valve implantation with the 34 mm self-expanding CoreValve Evolut R: initial experience in 101 patients from a multicentre registry.

Kuhn C, Frerker C, Meyer AK, Kurz T, Schäfer U, Deuschl F, Abdel-Wahab M, Schewel D, Elghalban A, Kuck KH, Frey N, Frank D.

EuroIntervention. 2018 Jun 8;14(3):e301-e305. doi: 10.4244/EIJ-D-17-01153.

32.

Matched comparison of next- and early-generation balloon-expandable transcatheter heart valve implantations in failed surgical aortic bioprostheses.

Seiffert M, Treede H, Schofer J, Linke A, Woehrle J, Baumbach H, Mehilli J, Bapat V, Simonato M, Walther T, Kullmer M, Boekstegers P, Ensminger S, Kurz T, Eltchaninoff H, Rastan A, Werner N, de Weger A, Frerker C, Lauer B, Muller O, Whisenant B, Thukkani A, Weisz G, Dvir D.

EuroIntervention. 2018 Jul 20;14(4):e397-e404. doi: 10.4244/EIJ-D-17-00546.

33.

Health related quality of life after extracorporeal cardiopulmonary resuscitation in refractory cardiac arrest.

Spangenberg T, Schewel J, Dreher A, Meincke F, Bahlmann E, van der Schalk H, Kreidel F, Frerker C, Stoeck M, Bein B, Kuck KH, Ghanem A.

Resuscitation. 2018 Jun;127:73-78. doi: 10.1016/j.resuscitation.2018.03.036. Epub 2018 Apr 4.

PMID:
29626610
34.

Rapid Deployment Versus Conventional Bioprosthetic Valve Replacement for Aortic Stenosis.

Ensminger S, Fujita B, Bauer T, Möllmann H, Beckmann A, Bekeredjian R, Bleiziffer S, Landwehr S, Hamm CW, Mohr FW, Katus HA, Harringer W, Walther T, Frerker C; GARY Executive Board.

J Am Coll Cardiol. 2018 Apr 3;71(13):1417-1428. doi: 10.1016/j.jacc.2018.01.065.

35.

Correlation of tricuspid regurgitation and new pacemaker implantation in patients undergoing transcatheter aortic valve implantation.

Schewel D, Schewel J, Schlüter M, Kreidel F, Schmidt T, Schmoeckel M, Elsässer A, Kuck KH, Frerker C.

Int J Cardiol. 2018 Jun 15;261:37-41. doi: 10.1016/j.ijcard.2018.03.030. Epub 2018 Mar 13.

PMID:
29572082
36.

Conscious Sedation Versus General Anesthesia in Transcatheter Aortic Valve Replacement: The German Aortic Valve Registry.

Husser O, Fujita B, Hengstenberg C, Frerker C, Beckmann A, Möllmann H, Walther T, Bekeredjian R, Böhm M, Pellegrini C, Bleiziffer S, Lange R, Mohr F, Hamm CW, Bauer T, Ensminger S; GARY Executive Board.

JACC Cardiovasc Interv. 2018 Mar 26;11(6):567-578. doi: 10.1016/j.jcin.2017.12.019.

37.

Treatment of Aortic Stenosis With a Self-Expanding, Resheathable Transcatheter Valve: One-Year Results of the International Multicenter Portico Transcatheter Aortic Valve Implantation System Study.

Linke A, Holzhey D, Möllmann H, Manoharan G, Schäfer U, Frerker C, Worthley SG, van Boven AJ, Redwood S, Kovac J, Butter C, Søndergaard L, Lauten A, Schymik G, Walther T.

Circ Cardiovasc Interv. 2018 Feb;11(2):e005206. doi: 10.1161/CIRCINTERVENTIONS.117.005206.

PMID:
29444998
38.

Heart Failure Interventions Targeting Impaired Left Ventricles in Structural Heart Disease.

Kitamura M, Schmidt T, Kuck KH, Frerker C.

Curr Cardiol Rep. 2018 Feb 12;20(2):8. doi: 10.1007/s11886-018-0950-6. Review.

PMID:
29435772
39.

Transcatheter Aortic Valve Replacement in Pure Native Aortic Valve Regurgitation.

Yoon SH, Schmidt T, Bleiziffer S, Schofer N, Fiorina C, Munoz-Garcia AJ, Yzeiraj E, Amat-Santos IJ, Tchetche D, Jung C, Fujita B, Mangieri A, Deutsch MA, Ubben T, Deuschl F, Kuwata S, De Biase C, Williams T, Dhoble A, Kim WK, Ferrari E, Barbanti M, Vollema EM, Miceli A, Giannini C, Attizzani GF, Kong WKF, Gutierrez-Ibanes E, Jimenez Diaz VA, Wijeysundera HC, Kaneko H, Chakravarty T, Makar M, Sievert H, Hengstenberg C, Prendergast BD, Vincent F, Abdel-Wahab M, Nombela-Franco L, Silaschi M, Tarantini G, Butter C, Ensminger SM, Hildick-Smith D, Petronio AS, Yin WH, De Marco F, Testa L, Van Mieghem NM, Whisenant BK, Kuck KH, Colombo A, Kar S, Moris C, Delgado V, Maisano F, Nietlispach F, Mack MJ, Schofer J, Schaefer U, Bax JJ, Frerker C, Latib A, Makkar RR.

J Am Coll Cardiol. 2017 Dec 5;70(22):2752-2763. doi: 10.1016/j.jacc.2017.10.006.

40.

Trends in practice and outcomes from 2011 to 2015 for surgical aortic valve replacement: an update from the German Aortic Valve Registry on 42 776 patients.

Fujita B, Ensminger S, Bauer T, Möllmann H, Beckmann A, Bekeredjian R, Bleiziffer S, Schäfer E, Hamm CW, Mohr FW, Katus HA, Harringer W, Walther T, Frerker C; GARY Executive Board.

Eur J Cardiothorac Surg. 2018 Mar 1;53(3):552-559. doi: 10.1093/ejcts/ezx408.

PMID:
29190355
41.

Antegrade-transseptal approach for left ventricular tachyarrhythmia in patients with previous Mitraclip implantation.

Hayashi K, Heeger CH, Mathew S, Maurer T, Lemes C, Riedl J, Reißmann B, Frerker C, Geidel S, Schmoeckel M, Saguner AM, Santoro F, Tilz RR, Metzner A, Kuck KH, Ouyang F.

Europace. 2018 Sep 1;20(9):1527-1534. doi: 10.1093/europace/eux243.

PMID:
29092036
42.

How should I treat a rupture of the interatrial septum with haemodynamically relevant right-to-left shunt during MitraClip implantation?

Schmidt T, Alessandrini H, Kreidel F, Spangenberg T, Schlüter M, Kannmacher J, Bader R, Thielsen T, Kuck KH, Frerker C, Casserly IP, Behan MWH, Scott A, Yerramasu A, Japp A, Pessotto R, Northridge DB.

EuroIntervention. 2017 Oct 20;13(8):1007-1010. doi: 10.4244/EIJ-D-16-00869. No abstract available.

43.

The International Multicenter TriValve Registry: Which Patients Are Undergoing Transcatheter Tricuspid Repair?

Taramasso M, Hahn RT, Alessandrini H, Latib A, Attinger-Toller A, Braun D, Brochet E, Connelly KA, Denti P, Deuschl F, Englmaier A, Fam N, Frerker C, Hausleiter J, Juliard JM, Kaple R, Kreidel F, Kuck KH, Kuwata S, Ancona M, Malasa M, Nazif T, Nickenig G, Nietlispach F, Pozzoli A, Schäfer U, Schofer J, Schueler R, Tang G, Vahanian A, Webb JG, Yzeiraj E, Maisano F, Leon MB.

JACC Cardiovasc Interv. 2017 Oct 9;10(19):1982-1990. doi: 10.1016/j.jcin.2017.08.011.

44.

[Interventional catheter treatment of tricuspid valve regurgitation].

Wißt T, Kreidel F, Schlüter M, Kuck KH, Frerker C.

Internist (Berl). 2017 Nov;58(11):1222-1230. doi: 10.1007/s00108-017-0329-6. Review. German.

PMID:
28932873
45.

Update on the significance of postprocedural aortic regurgitation after transcatheter aortic valve replacement on postprocedural prognosis.

Schmidt-Salzmann M, Schlüter M, Kuck KH, Frerker C.

Future Cardiol. 2017 Aug 23. doi: 10.2217/fca-2017-0035. [Epub ahead of print]

PMID:
28832195
46.

Percutaneous Edge-to-Edge Repair of Recurrent Severe Mitral Regurgitation After Surgical Mitral Valve Repair.

Braun D, Frerker C, Körber MI, Gaemperli O, Patzelt J, Schaefer U, Hammerstingl C, Boekstegers P, Ott I, Ince H, Thiele H, Hausleiter J.

J Am Coll Cardiol. 2017 Jul 25;70(4):504-505. doi: 10.1016/j.jacc.2017.05.045. No abstract available.

47.

Multicenter Experience With Treatment of Residual Mitral Regurgitation After MitraClip Implantation Using Amplatzer Closure Device: Mid-Term Results.

Taramasso M, Alessandrini H, Kuwata S, Biasco L, Nietlispach F, Gaemperli O, Zuber M, Linka A, Pedrazzini G, Kreidel F, Frerker C, Kuck KH, Maisano F.

JACC Cardiovasc Interv. 2017 May 8;10(9):966-970. doi: 10.1016/j.jcin.2017.02.011. No abstract available.

48.

Left ventricular function determines the survival benefit for women over men after transcatheter aortic valve implantation (TAVI).

Bauer T, Möllmann H, Beckmann A, Ensminger S, Frerker C, Holzhey D, Berkowitsch A, Zahn R, Mohr F, Hamm CW, Walther T.

EuroIntervention. 2017 Jul 20;13(4):467-474. doi: 10.4244/EIJ-D-16-00622.

49.

Matched Comparison of Self-Expanding Transcatheter Heart Valves for the Treatment of Failed Aortic Surgical Bioprosthesis: Insights From the Valve-in-Valve International Data Registry (VIVID).

Alnasser S, Cheema AN, Simonato M, Barbanti M, Edwards J, Kornowski R, Horlick E, Wijeysundera HC, Testa L, Bedogni F, Amrane H, Walther T, Pelletier M, Latib A, Laborde JC, Hildick-Smith D, Kim WK, Tchetche D, Agrifoglio M, Sinning JM, van Boven AJ, Kefer J, Frerker C, van Mieghem NM, Linke A, Worthley S, Asgar A, Sgroi C, Aziz M, Danenberg HD, Labinaz M, Manoharan G, Cheung A, Webb JG, Dvir D; Valve-in-Valve International Data Registry Investigators.

Circ Cardiovasc Interv. 2017 Apr;10(4). pii: e004392. doi: 10.1161/CIRCINTERVENTIONS.116.004392.

PMID:
28400461
50.

In-hospital mortality in propensity-score matched low-risk patients undergoing routine isolated surgical or transfemoral transcatheter aortic valve replacement in 2014 in Germany.

Frerker C, Bestehorn K, Schlüter M, Bestehorn M, Hamm CW, Möllmann H, Katus HA, Kuck KH.

Clin Res Cardiol. 2017 Aug;106(8):610-617. doi: 10.1007/s00392-017-1097-y. Epub 2017 Mar 10.

PMID:
28283745

Supplemental Content

Loading ...
Support Center